Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins
G. C. Rask, C. Taslim, A. Bayanjargal, M. V. Cannon, J. Selich-Anderson, J. Crow, A. Duncan, E. R. Theisen
This study shows seclidemstat inhibits the transcriptional activity of multiple FET fusion oncoproteins in vitro, suggesting it as a promising treatment for FET-rearranged sarcomas.
bioRxiv · May 19, 2024 · PreprintCancer Biology